COVID-19 Impact on Global Recombinant Human Insulin Market Insights, Forecast to 2026

COVID-19 Impact on Global Recombinant Human Insulin Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Recombinant Human Insulin Product Introduction
1.2 Market Segments
1.3 Key Recombinant Human Insulin Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Recombinant Human Insulin Market Size Growth Rate by Type
1.4.2 Type I
1.4.3 Type II
1.5 Market by Application
1.5.1 Global Recombinant Human Insulin Market Size Growth Rate by Application
1.5.2 Type 1 Diabetes Mellitus
1.5.3 Type 2 Diabetes Mellitus
1.6 Coronavirus Disease 2019 (Covid-19): Recombinant Human Insulin Industry Impact
1.6.1 How the Covid-19 is Affecting the Recombinant Human Insulin Industry
1.6.1.1 Recombinant Human Insulin Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Recombinant Human Insulin Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Recombinant Human Insulin Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Executive Summary
2.1 Global Recombinant Human Insulin Market Size Estimates and Forecasts
2.1.1 Global Recombinant Human Insulin Revenue 2015-2026
2.1.2 Global Recombinant Human Insulin Sales 2015-2026
2.2 Recombinant Human Insulin Market Size by Region: 2020 Versus 2026
2.2.1 Global Recombinant Human Insulin Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Recombinant Human Insulin Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Recombinant Human Insulin Competitor Landscape by Players
3.1 Recombinant Human Insulin Sales by Manufacturers
3.1.1 Recombinant Human Insulin Sales by Manufacturers (2015-2020)
3.1.2 Recombinant Human Insulin Sales Market Share by Manufacturers (2015-2020)
3.2 Recombinant Human Insulin Revenue by Manufacturers
3.2.1 Recombinant Human Insulin Revenue by Manufacturers (2015-2020)
3.2.2 Recombinant Human Insulin Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Recombinant Human Insulin Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Recombinant Human Insulin Revenue in 2019
3.2.5 Global Recombinant Human Insulin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Recombinant Human Insulin Price by Manufacturers
3.4 Recombinant Human Insulin Manufacturing Base Distribution, Product Types
3.4.1 Recombinant Human Insulin Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Recombinant Human Insulin Product Type
3.4.3 Date of International Manufacturers Enter into Recombinant Human Insulin Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Recombinant Human Insulin Market Size by Type (2015-2020)
4.1.1 Global Recombinant Human Insulin Sales by Type (2015-2020)
4.1.2 Global Recombinant Human Insulin Revenue by Type (2015-2020)
4.1.3 Recombinant Human Insulin Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Recombinant Human Insulin Market Size Forecast by Type (2021-2026)
4.2.1 Global Recombinant Human Insulin Sales Forecast by Type (2021-2026)
4.2.2 Global Recombinant Human Insulin Revenue Forecast by Type (2021-2026)
4.2.3 Recombinant Human Insulin Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Recombinant Human Insulin Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Breakdown Data by Application (2015-2026)
5.1 Global Recombinant Human Insulin Market Size by Application (2015-2020)
5.1.1 Global Recombinant Human Insulin Sales by Application (2015-2020)
5.1.2 Global Recombinant Human Insulin Revenue by Application (2015-2020)
5.1.3 Recombinant Human Insulin Price by Application (2015-2020)
5.2 Recombinant Human Insulin Market Size Forecast by Application (2021-2026)
5.2.1 Global Recombinant Human Insulin Sales Forecast by Application (2021-2026)
5.2.2 Global Recombinant Human Insulin Revenue Forecast by Application (2021-2026)
5.2.3 Global Recombinant Human Insulin Price Forecast by Application (2021-2026)
6 North America
6.1 North America Recombinant Human Insulin by Country
6.1.1 North America Recombinant Human Insulin Sales by Country
6.1.2 North America Recombinant Human Insulin Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Recombinant Human Insulin Market Facts & Figures by Type
6.3 North America Recombinant Human Insulin Market Facts & Figures by Application
7 Europe
7.1 Europe Recombinant Human Insulin by Country
7.1.1 Europe Recombinant Human Insulin Sales by Country
7.1.2 Europe Recombinant Human Insulin Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Recombinant Human Insulin Market Facts & Figures by Type
7.3 Europe Recombinant Human Insulin Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Recombinant Human Insulin by Region
8.1.1 Asia Pacific Recombinant Human Insulin Sales by Region
8.1.2 Asia Pacific Recombinant Human Insulin Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Recombinant Human Insulin Market Facts & Figures by Type
8.3 Asia Pacific Recombinant Human Insulin Market Facts & Figures by Application
9 Latin America
9.1 Latin America Recombinant Human Insulin by Country
9.1.1 Latin America Recombinant Human Insulin Sales by Country
9.1.2 Latin America Recombinant Human Insulin Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Recombinant Human Insulin Market Facts & Figures by Type
9.3 Central & South America Recombinant Human Insulin Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Recombinant Human Insulin by Country
10.1.1 Middle East and Africa Recombinant Human Insulin Sales by Country
10.1.2 Middle East and Africa Recombinant Human Insulin Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Recombinant Human Insulin Market Facts & Figures by Type
10.3 Middle East and Africa Recombinant Human Insulin Market Facts & Figures by Application
11 Company Profiles
11.1 Akron Biotech
11.1.1 Akron Biotech Corporation Information
11.1.2 Akron Biotech Description, Business Overview and Total Revenue
11.1.3 Akron Biotech Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Akron Biotech Recombinant Human Insulin Products Offered
11.1.5 Akron Biotech Recent Development
11.2 Wockhardt
11.2.1 Wockhardt Corporation Information
11.2.2 Wockhardt Description, Business Overview and Total Revenue
11.2.3 Wockhardt Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Wockhardt Recombinant Human Insulin Products Offered
11.2.5 Wockhardt Recent Development
11.3 Dance Biopharm
11.3.1 Dance Biopharm Corporation Information
11.3.2 Dance Biopharm Description, Business Overview and Total Revenue
11.3.3 Dance Biopharm Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Dance Biopharm Recombinant Human Insulin Products Offered
11.3.5 Dance Biopharm Recent Development
11.4 Novo Nordisk
11.4.1 Novo Nordisk Corporation Information
11.4.2 Novo Nordisk Description, Business Overview and Total Revenue
11.4.3 Novo Nordisk Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Novo Nordisk Recombinant Human Insulin Products Offered
11.4.5 Novo Nordisk Recent Development
11.5 Gan & Lee
11.5.1 Gan & Lee Corporation Information
11.5.2 Gan & Lee Description, Business Overview and Total Revenue
11.5.3 Gan & Lee Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Gan & Lee Recombinant Human Insulin Products Offered
11.5.5 Gan & Lee Recent Development
11.6 United Laboratories
11.6.1 United Laboratories Corporation Information
11.6.2 United Laboratories Description, Business Overview and Total Revenue
11.6.3 United Laboratories Sales, Revenue and Gross Margin (2015-2020)
11.6.4 United Laboratories Recombinant Human Insulin Products Offered
11.6.5 United Laboratories Recent Development
11.7 Dongbro Pharmaceuticri
11.7.1 Dongbro Pharmaceuticri Corporation Information
11.7.2 Dongbro Pharmaceuticri Description, Business Overview and Total Revenue
11.7.3 Dongbro Pharmaceuticri Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Dongbro Pharmaceuticri Recombinant Human Insulin Products Offered
11.7.5 Dongbro Pharmaceuticri Recent Development
11.1 Akron Biotech
11.1.1 Akron Biotech Corporation Information
11.1.2 Akron Biotech Description, Business Overview and Total Revenue
11.1.3 Akron Biotech Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Akron Biotech Recombinant Human Insulin Products Offered
11.1.5 Akron Biotech Recent Development
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Recombinant Human Insulin Market Estimates and Projections by Region
12.1.1 Global Recombinant Human Insulin Sales Forecast by Regions 2021-2026
12.1.2 Global Recombinant Human Insulin Revenue Forecast by Regions 2021-2026
12.2 North America Recombinant Human Insulin Market Size Forecast (2021-2026)
12.2.1 North America: Recombinant Human Insulin Sales Forecast (2021-2026)
12.2.2 North America: Recombinant Human Insulin Revenue Forecast (2021-2026)
12.2.3 North America: Recombinant Human Insulin Market Size Forecast by Country (2021-2026)
12.3 Europe Recombinant Human Insulin Market Size Forecast (2021-2026)
12.3.1 Europe: Recombinant Human Insulin Sales Forecast (2021-2026)
12.3.2 Europe: Recombinant Human Insulin Revenue Forecast (2021-2026)
12.3.3 Europe: Recombinant Human Insulin Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Recombinant Human Insulin Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Recombinant Human Insulin Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Recombinant Human Insulin Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Recombinant Human Insulin Market Size Forecast by Region (2021-2026)
12.5 Latin America Recombinant Human Insulin Market Size Forecast (2021-2026)
12.5.1 Latin America: Recombinant Human Insulin Sales Forecast (2021-2026)
12.5.2 Latin America: Recombinant Human Insulin Revenue Forecast (2021-2026)
12.5.3 Latin America: Recombinant Human Insulin Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Recombinant Human Insulin Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Recombinant Human Insulin Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Recombinant Human Insulin Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Recombinant Human Insulin Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Recombinant Human Insulin Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Recombinant Human Insulin Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
List of Tables
Table 1. Recombinant Human Insulin Market Segments
Table 2. Ranking of Global Top Recombinant Human Insulin Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Recombinant Human Insulin Market Size Growth Rate by Type 2020-2026 (g) & (US$ Million)
Table 4. Major Manufacturers of Type I
Table 5. Major Manufacturers of Type II
Table 6. COVID-19 Impact Global Market: (Four Recombinant Human Insulin Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for Recombinant Human Insulin Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for Recombinant Human Insulin Players to Combat Covid-19 Impact
Table 11. Global Recombinant Human Insulin Market Size Growth Rate by Application 2020-2026 (g)
Table 12. Global Recombinant Human Insulin Market Size by Region (g) & (US$ Million): 2020 VS 2026
Table 13. Global Recombinant Human Insulin Sales by Regions 2015-2020 (g)
Table 14. Global Recombinant Human Insulin Sales Market Share by Regions (2015-2020)
Table 15. Global Recombinant Human Insulin Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Recombinant Human Insulin Sales by Manufacturers (2015-2020) (g)
Table 17. Global Recombinant Human Insulin Sales Share by Manufacturers (2015-2020)
Table 18. Global Recombinant Human Insulin Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Recombinant Human Insulin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant Human Insulin as of 2019)
Table 20. Recombinant Human Insulin Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Recombinant Human Insulin Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Recombinant Human Insulin Price (2015-2020) (USD/mg)
Table 23. Recombinant Human Insulin Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Recombinant Human Insulin Product Type
Table 25. Date of International Manufacturers Enter into Recombinant Human Insulin Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Recombinant Human Insulin Sales by Type (2015-2020) (g)
Table 28. Global Recombinant Human Insulin Sales Share by Type (2015-2020)
Table 29. Global Recombinant Human Insulin Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Recombinant Human Insulin Revenue Share by Type (2015-2020)
Table 31. Recombinant Human Insulin Average Selling Price (ASP) by Type 2015-2020 (USD/mg)
Table 32. Global Recombinant Human Insulin Sales by Application (2015-2020) (g)
Table 33. Global Recombinant Human Insulin Sales Share by Application (2015-2020)
Table 34. North America Recombinant Human Insulin Sales by Country (2015-2020) (g)
Table 35. North America Recombinant Human Insulin Sales Market Share by Country (2015-2020)
Table 36. North America Recombinant Human Insulin Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Recombinant Human Insulin Revenue Market Share by Country (2015-2020)
Table 38. North America Recombinant Human Insulin Sales by Type (2015-2020) (g)
Table 39. North America Recombinant Human Insulin Sales Market Share by Type (2015-2020)
Table 40. North America Recombinant Human Insulin Sales by Application (2015-2020) (g)
Table 41. North America Recombinant Human Insulin Sales Market Share by Application (2015-2020)
Table 42. Europe Recombinant Human Insulin Sales by Country (2015-2020) (g)
Table 43. Europe Recombinant Human Insulin Sales Market Share by Country (2015-2020)
Table 44. Europe Recombinant Human Insulin Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Recombinant Human Insulin Revenue Market Share by Country (2015-2020)
Table 46. Europe Recombinant Human Insulin Sales by Type (2015-2020) (g)
Table 47. Europe Recombinant Human Insulin Sales Market Share by Type (2015-2020)
Table 48. Europe Recombinant Human Insulin Sales by Application (2015-2020) (g)
Table 49. Europe Recombinant Human Insulin Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Recombinant Human Insulin Sales by Region (2015-2020) (g)
Table 51. Asia Pacific Recombinant Human Insulin Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Recombinant Human Insulin Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Recombinant Human Insulin Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Recombinant Human Insulin Sales by Type (2015-2020) (g)
Table 55. Asia Pacific Recombinant Human Insulin Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Recombinant Human Insulin Sales by Application (2015-2020) (g)
Table 57. Asia Pacific Recombinant Human Insulin Sales Market Share by Application (2015-2020)
Table 58. Latin America Recombinant Human Insulin Sales by Country (2015-2020) (g)
Table 59. Latin America Recombinant Human Insulin Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Recombinant Human Insulin Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Recombinant Human Insulin Revenue Market Share by Country (2015-2020)
Table 62. Latin America Recombinant Human Insulin Sales by Type (2015-2020) (g)
Table 63. Latin America Recombinant Human Insulin Sales Market Share by Type (2015-2020)
Table 64. Latin America Recombinant Human Insulin Sales by Application (2015-2020) (g)
Table 65. Latin America Recombinant Human Insulin Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Recombinant Human Insulin Sales by Country (2015-2020) (g)
Table 67. Middle East and Africa Recombinant Human Insulin Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Recombinant Human Insulin Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Recombinant Human Insulin Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Recombinant Human Insulin Sales by Type (2015-2020) (g)
Table 71. Middle East and Africa Recombinant Human Insulin Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Recombinant Human Insulin Sales by Application (2015-2020) (g)
Table 73. Middle East and Africa Recombinant Human Insulin Sales Market Share by Application (2015-2020)
Table 74. Akron Biotech Corporation Information
Table 75. Akron Biotech Description and Major Businesses
Table 76. Akron Biotech Recombinant Human Insulin Production (g), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2015-2020)
Table 77. Akron Biotech Product
Table 78. Akron Biotech Recent Development
Table 79. Wockhardt Corporation Information
Table 80. Wockhardt Description and Major Businesses
Table 81. Wockhardt Recombinant Human Insulin Production (g), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2015-2020)
Table 82. Wockhardt Product
Table 83. Wockhardt Recent Development
Table 84. Dance Biopharm Corporation Information
Table 85. Dance Biopharm Description and Major Businesses
Table 86. Dance Biopharm Recombinant Human Insulin Production (g), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2015-2020)
Table 87. Dance Biopharm Product
Table 88. Dance Biopharm Recent Development
Table 89. Novo Nordisk Corporation Information
Table 90. Novo Nordisk Description and Major Businesses
Table 91. Novo Nordisk Recombinant Human Insulin Production (g), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2015-2020)
Table 92. Novo Nordisk Product
Table 93. Novo Nordisk Recent Development
Table 94. Gan & Lee Corporation Information
Table 95. Gan & Lee Description and Major Businesses
Table 96. Gan & Lee Recombinant Human Insulin Production (g), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2015-2020)
Table 97. Gan & Lee Product
Table 98. Gan & Lee Recent Development
Table 99. United Laboratories Corporation Information
Table 100. United Laboratories Description and Major Businesses
Table 101. United Laboratories Recombinant Human Insulin Production (g), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2015-2020)
Table 102. United Laboratories Product
Table 103. United Laboratories Recent Development
Table 104. Dongbro Pharmaceuticri Corporation Information
Table 105. Dongbro Pharmaceuticri Description and Major Businesses
Table 106. Dongbro Pharmaceuticri Recombinant Human Insulin Production (g), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2015-2020)
Table 107. Dongbro Pharmaceuticri Product
Table 108. Dongbro Pharmaceuticri Recent Development
Table 109. Global Recombinant Human Insulin Sales Forecast by Regions (2021-2026) (g)
Table 110. Global Recombinant Human Insulin Sales Market Share Forecast by Regions (2021-2026)
Table 111. Global Recombinant Human Insulin Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 112. Global Recombinant Human Insulin Revenue Market Share Forecast by Regions (2021-2026)
Table 113. North America: Recombinant Human Insulin Sales Forecast by Country (2021-2026) (g)
Table 114. North America: Recombinant Human Insulin Revenue Forecast by Country (2021-2026) (US$ Million)
Table 115. Europe: Recombinant Human Insulin Sales Forecast by Country (2021-2026) (g)
Table 116. Europe: Recombinant Human Insulin Revenue Forecast by Country (2021-2026) (US$ Million)
Table 117. Asia Pacific: Recombinant Human Insulin Sales Forecast by Region (2021-2026) (g)
Table 118. Asia Pacific: Recombinant Human Insulin Revenue Forecast by Region (2021-2026) (US$ Million)
Table 119. Latin America: Recombinant Human Insulin Sales Forecast by Country (2021-2026) (g)
Table 120. Latin America: Recombinant Human Insulin Revenue Forecast by Country (2021-2026) (US$ Million)
Table 121. Middle East and Africa: Recombinant Human Insulin Sales Forecast by Country (2021-2026) (g)
Table 122. Middle East and Africa: Recombinant Human Insulin Revenue Forecast by Country (2021-2026) (US$ Million)
Table 123. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 124. Key Challenges
Table 125. Market Risks
Table 126. Main Points Interviewed from Key Recombinant Human Insulin Players
Table 127. Recombinant Human Insulin Customers List
Table 128. Recombinant Human Insulin Distributors List
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
List of Figures
Figure 1. Recombinant Human Insulin Product Picture
Figure 2. Global Recombinant Human Insulin Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Recombinant Human Insulin Sales Market Share by Application in 2020 & 2026
Figure 6. Type 1 Diabetes Mellitus
Figure 7. Type 2 Diabetes Mellitus
Figure 8. Recombinant Human Insulin Report Years Considered
Figure 9. Global Recombinant Human Insulin Market Size 2015-2026 (US$ Million)
Figure 10. Global Recombinant Human Insulin Sales 2015-2026 (g)
Figure 11. Global Recombinant Human Insulin Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Global Recombinant Human Insulin Sales Market Share by Region (2015-2020)
Figure 13. Global Recombinant Human Insulin Sales Market Share by Region in 2019
Figure 14. Global Recombinant Human Insulin Revenue Market Share by Region (2015-2020)
Figure 15. Global Recombinant Human Insulin Revenue Market Share by Region in 2019
Figure 16. Global Recombinant Human Insulin Sales Share by Manufacturer in 2019
Figure 17. The Top 10 and 5 Players Market Share by Recombinant Human Insulin Revenue in 2019
Figure 18. Recombinant Human Insulin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Recombinant Human Insulin Sales Market Share by Type (2015-2020)
Figure 20. Global Recombinant Human Insulin Sales Market Share by Type in 2019
Figure 21. Global Recombinant Human Insulin Revenue Market Share by Type (2015-2020)
Figure 22. Global Recombinant Human Insulin Revenue Market Share by Type in 2019
Figure 23. Global Recombinant Human Insulin Market Share by Price Range (2015-2020)
Figure 24. Global Recombinant Human Insulin Sales Market Share by Application (2015-2020)
Figure 25. Global Recombinant Human Insulin Sales Market Share by Application in 2019
Figure 26. Global Recombinant Human Insulin Revenue Market Share by Application (2015-2020)
Figure 27. Global Recombinant Human Insulin Revenue Market Share by Application in 2019
Figure 28. North America Recombinant Human Insulin Sales Growth Rate 2015-2020 (g)
Figure 29. North America Recombinant Human Insulin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 30. North America Recombinant Human Insulin Sales Market Share by Country in 2019
Figure 31. North America Recombinant Human Insulin Revenue Market Share by Country in 2019
Figure 32. U.S. Recombinant Human Insulin Sales Growth Rate (2015-2020) (g)
Figure 33. U.S. Recombinant Human Insulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Canada Recombinant Human Insulin Sales Growth Rate (2015-2020) (g)
Figure 35. Canada Recombinant Human Insulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. North America Recombinant Human Insulin Market Share by Type in 2019
Figure 37. North America Recombinant Human Insulin Market Share by Application in 2019
Figure 38. Europe Recombinant Human Insulin Sales Growth Rate 2015-2020 (g)
Figure 39. Europe Recombinant Human Insulin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 40. Europe Recombinant Human Insulin Sales Market Share by Country in 2019
Figure 41. Europe Recombinant Human Insulin Revenue Market Share by Country in 2019
Figure 42. Germany Recombinant Human Insulin Sales Growth Rate (2015-2020) (g)
Figure 43. Germany Recombinant Human Insulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. France Recombinant Human Insulin Sales Growth Rate (2015-2020) (g)
Figure 45. France Recombinant Human Insulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. U.K. Recombinant Human Insulin Sales Growth Rate (2015-2020) (g)
Figure 47. U.K. Recombinant Human Insulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Italy Recombinant Human Insulin Sales Growth Rate (2015-2020) (g)
Figure 49. Italy Recombinant Human Insulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Russia Recombinant Human Insulin Sales Growth Rate (2015-2020) (g)
Figure 51. Russia Recombinant Human Insulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Europe Recombinant Human Insulin Market Share by Type in 2019
Figure 53. Europe Recombinant Human Insulin Market Share by Application in 2019
Figure 54. Asia Pacific Recombinant Human Insulin Sales Growth Rate 2015-2020 (g)
Figure 55. Asia Pacific Recombinant Human Insulin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 56. Asia Pacific Recombinant Human Insulin Sales Market Share by Region in 2019
Figure 57. Asia Pacific Recombinant Human Insulin Revenue Market Share by Region in 2019
Figure 58. China Recombinant Human Insulin Sales Growth Rate (2015-2020) (g)
Figure 59. China Recombinant Human Insulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Japan Recombinant Human Insulin Sales Growth Rate (2015-2020) (g)
Figure 61. Japan Recombinant Human Insulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. South Korea Recombinant Human Insulin Sales Growth Rate (2015-2020) (g)
Figure 63. South Korea Recombinant Human Insulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. India Recombinant Human Insulin Sales Growth Rate (2015-2020) (g)
Figure 65. India Recombinant Human Insulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Australia Recombinant Human Insulin Sales Growth Rate (2015-2020) (g)
Figure 67. Australia Recombinant Human Insulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Taiwan Recombinant Human Insulin Sales Growth Rate (2015-2020) (g)
Figure 69. Taiwan Recombinant Human Insulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Indonesia Recombinant Human Insulin Sales Growth Rate (2015-2020) (g)
Figure 71. Indonesia Recombinant Human Insulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Thailand Recombinant Human Insulin Sales Growth Rate (2015-2020) (g)
Figure 73. Thailand Recombinant Human Insulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Malaysia Recombinant Human Insulin Sales Growth Rate (2015-2020) (g)
Figure 75. Malaysia Recombinant Human Insulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Philippines Recombinant Human Insulin Sales Growth Rate (2015-2020) (g)
Figure 77. Philippines Recombinant Human Insulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Vietnam Recombinant Human Insulin Sales Growth Rate (2015-2020) (g)
Figure 79. Vietnam Recombinant Human Insulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Asia Pacific Recombinant Human Insulin Market Share by Type in 2019
Figure 81. Asia Pacific Recombinant Human Insulin Market Share by Application in 2019
Figure 82. Latin America Recombinant Human Insulin Sales Growth Rate 2015-2020 (g)
Figure 83. Latin America Recombinant Human Insulin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 84. Latin America Recombinant Human Insulin Sales Market Share by Country in 2019
Figure 85. Latin America Recombinant Human Insulin Revenue Market Share by Country in 2019
Figure 86. Mexico Recombinant Human Insulin Sales Growth Rate (2015-2020) (g)
Figure 87. Mexico Recombinant Human Insulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Brazil Recombinant Human Insulin Sales Growth Rate (2015-2020) (g)
Figure 89. Brazil Recombinant Human Insulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Argentina Recombinant Human Insulin Sales Growth Rate (2015-2020) (g)
Figure 91. Argentina Recombinant Human Insulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Latin America Recombinant Human Insulin Market Share by Type in 2019
Figure 93. Latin America Recombinant Human Insulin Market Share by Application in 2019
Figure 94. Middle East and Africa Recombinant Human Insulin Sales Growth Rate 2015-2020 (g)
Figure 95. Middle East and Africa Recombinant Human Insulin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 96. Middle East and Africa Recombinant Human Insulin Sales Market Share by Country in 2019
Figure 97. Middle East and Africa Recombinant Human Insulin Revenue Market Share by Country in 2019
Figure 98. Turkey Recombinant Human Insulin Sales Growth Rate (2015-2020) (g)
Figure 99. Turkey Recombinant Human Insulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 100. Saudi Arabia Recombinant Human Insulin Sales Growth Rate (2015-2020) (g)
Figure 101. Saudi Arabia Recombinant Human Insulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. U.A.E Recombinant Human Insulin Sales Growth Rate (2015-2020) (g)
Figure 103. U.A.E Recombinant Human Insulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Middle East and Africa Recombinant Human Insulin Market Share by Type in 2019
Figure 105. Middle East and Africa Recombinant Human Insulin Market Share by Application in 2019
Figure 106. Akron Biotech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 107. Wockhardt Total Revenue (US$ Million): 2019 Compared with 2018
Figure 108. Dance Biopharm Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. Novo Nordisk Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Gan & Lee Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. United Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Dongbro Pharmaceuticri Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. North America Recombinant Human Insulin Sales Growth Rate Forecast (2021-2026) (g)
Figure 114. North America Recombinant Human Insulin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Europe Recombinant Human Insulin Sales Growth Rate Forecast (2021-2026) (g)
Figure 116. Europe Recombinant Human Insulin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Asia Pacific Recombinant Human Insulin Sales Growth Rate Forecast (2021-2026) (g)
Figure 118. Asia Pacific Recombinant Human Insulin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Latin America Recombinant Human Insulin Sales Growth Rate Forecast (2021-2026) (g)
Figure 120. Latin America Recombinant Human Insulin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Middle East and Africa Recombinant Human Insulin Sales Growth Rate Forecast (2021-2026) (g)
Figure 122. Middle East and Africa Recombinant Human Insulin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Porter's Five Forces Analysis
Figure 124. Channels of Distribution
Figure 125. Distributors Profiles
Figure 126. Bottom-up and Top-down Approaches for This Report
Figure 127.

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Sanger Sequencing Service Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 149

According to our LPI (LP Information) latest study, the global Sanger Sequencing Service market size was valued at US$ 209 million in 2023. With growing demand in downstream market, the Sanger Sequencing Service is forecast to a readjusted size of US$ 206.7 million by 2030 with a CAGR of -0.2% during review period. The research report highlights the growth potential of the global Sanger Sequencing Service market. Sanger Sequencing Service are expected to show stable growth in the future ......

Global Whole Exome Sequencing Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 110

According to our LPI (LP Information) latest study, the global Whole Exome Sequencing market size was valued at US$ 289.6 million in 2023. With growing demand in downstream market, the Whole Exome Sequencing is forecast to a readjusted size of US$ 633.2 million by 2030 with a CAGR of 11.8% during review period. The research report highlights the growth potential of the global Whole Exome Sequencing market. Whole Exome Sequencing are expected to show stable growth in the future market. Ho......

Global Single Nucleotide Polymorphism (SNP) Genotyping Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 154

According to our LPI (LP Information) latest study, the global Single Nucleotide Polymorphism (SNP) Genotyping market size was valued at US$ 16530 million in 2023. With growing demand in downstream market, the Single Nucleotide Polymorphism (SNP) Genotyping is forecast to a readjusted size of US$ 66080 million by 2030 with a CAGR of 21.9% during review period. The research report highlights the growth potential of the global Single Nucleotide Polymorphism (SNP) Genotyping market. Single ......

Global CRISPR and CRISPR-Associated (Cas) Genes Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 125

According to our LPI (LP Information) latest study, the global CRISPR and CRISPR-Associated (Cas) Genes market size was valued at US$ 1354.3 million in 2023. With growing demand in downstream market, the CRISPR and CRISPR-Associated (Cas) Genes is forecast to a readjusted size of US$ 10020 million by 2030 with a CAGR of 33.1% during review period. The research report highlights the growth potential of the global CRISPR and CRISPR-Associated (Cas) Genes market. CRISPR and CRISPR-Associate......

Global Polymerase Chain Reaction (Pcr) Products Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 120

Market Overview of Global Polymerase Chain Reaction (Pcr) Products market: According to our latest research, the global Polymerase Chain Reaction (Pcr) Products market looks promising in the next 5 years. As of 2022, the global Polymerase Chain Reaction (Pcr) Products market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents......

Next Generation Sequencing - Global Market Insights and Sales Trends 2024

Published: 27-Dec-2023        Price: US 3350 Onwards        Pages: 102

This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Next Generation Sequencing, with both quanti......

Polymerase Chain Reaction (PCR) Products - Global Market Insights and Sales Trends 2024

Published: 27-Dec-2023        Price: US 3350 Onwards        Pages: 124

This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Polymerase Chain Reaction (PCR) Products, wi......

Global Genotyping Market Status and Outlook 2023-2028

Published: 26-Dec-2023        Price: US 3160 Onwards        Pages: 128

Genotyping is the technology that detects small genetic differences that can lead to major changes in phenotype, including both physical differences that make us unique and pathological changes underlying disease. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals wh......

Global Pyrosequencing Professional Survey Report 2023, Forecast to 2028

Published: 26-Dec-2023        Price: US 3280 Onwards        Pages: 101

Pyrosequencing is a method of DNA sequencing that detects light emitted from nucleotide bases.  Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital f......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs